Related references
Note: Only part of the references are listed.Human Monoclonal Antibody MBL-HCV1 Delays HCV Viral Rebound Following Liver Transplantation: A Randomized Controlled Study
R. T. Chung et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
Glycan Shifting on Hepatitis C Virus (HCV) E2 Glycoprotein Is a Mechanism for Escape from Broadly Neutralizing Antibodies
Homer Pantua et al.
JOURNAL OF MOLECULAR BIOLOGY (2013)
Cooperativity in Virus Neutralization by Human Monoclonal Antibodies to Two Adjacent Regions Located at the Amino Terminus of Hepatitis C Virus E2 Glycoprotein
Zhenyong Keck et al.
JOURNAL OF VIROLOGY (2013)
MEGA6: Molecular Evolutionary Genetics Analysis Version 6.0
Koichiro Tamura et al.
MOLECULAR BIOLOGY AND EVOLUTION (2013)
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
Troels K. H. Scheel et al.
NATURE MEDICINE (2013)
Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options
Ira M. Jacobson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Current and Future Therapies for Hepatitis C Virus Infection
T. Jake Liang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Nucleotide Polymerase Inhibitor Sofosbuvir plus Ribavirin for Hepatitis C
Edward J. Gane et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection
Eric Lawitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Structural Basis of HCV Neutralization by Human Monoclonal Antibodies Resistant to Viral Neutralization Escape
Thomas Krey et al.
PLOS PATHOGENS (2013)
Naturally Occurring Antibodies That Recognize Linear Epitopes in the Amino Terminus of the Hepatitis C Virus E2 Protein Confer Noninterfering, Additive Neutralization
Alexander W. Tarr et al.
JOURNAL OF VIROLOGY (2012)
Toward a Hepatitis C Virus Vaccine: the Structural Basis of Hepatitis C Virus Neutralization by AP33, a Broadly Neutralizing Antibody
Jane A. Potter et al.
JOURNAL OF VIROLOGY (2012)
Structure of Hepatitis C Virus Envelope Glycoprotein E2 Antigenic Site 412 to 423 in Complex with Antibody AP33
Leopold Kong et al.
JOURNAL OF VIROLOGY (2012)
Structural basis of hepatitis C virus neutralization by broadly neutralizing antibody HCV1
Leopold Kong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Human Monoclonal Antibodies to a Novel Cluster of Conformational Epitopes on HCV E2 with Resistance to Neutralization Escape in a Genotype 2a Isolate
Zhen-yong Keck et al.
PLOS PATHOGENS (2012)
Human Monoclonal Antibody HCV1 Effectively Prevents and Treats HCV Infection in Chimpanzees
Trevor J. Morin et al.
PLOS PATHOGENS (2012)
Relaxed acceptor site specificity of bacterial oligosaccharyltransferase in vivo
Flavio Schwarz et al.
GLYCOBIOLOGY (2011)
In Vivo Evaluation of the Cross-Genotype Neutralizing Activity of Polyclonal Antibodies Against Hepatitis C Virus
Philip Meuleman et al.
HEPATOLOGY (2011)
Neutralizing Monoclonal Antibodies against Hepatitis C Virus E2 Protein Bind Discontinuous Epitopes and Inhibit Infection at a Postattachment Step
Michelle C. Sabo et al.
JOURNAL OF VIROLOGY (2011)
Mapping a Region of Hepatitis C Virus E2 That Is Responsible for Escape from Neutralizing Antibodies and a Core CD81-Binding Region That Does Not Tolerate Neutralization Escape Mutations
Zhen-Yong Keck et al.
JOURNAL OF VIROLOGY (2011)
A genetically humanized mouse model for hepatitis C virus infection
Marcus Dorner et al.
NATURE (2011)
Spontaneous Control of Primary Hepatitis C Virus Infection and Immunity Against Persistent Reinfection
William O. Osburn et al.
GASTROENTEROLOGY (2010)
Role of N-Linked Glycans in the Functions of Hepatitis C Virus Envelope Proteins Incorporated into Infectious Virions
Francois Helle et al.
JOURNAL OF VIROLOGY (2010)
Mutations within a Conserved Region of the Hepatitis C Virus E2 Glycoprotein That Influence Virus-Receptor Interactions and Sensitivity to Neutralizing Antibodies
Simrat Dhillon et al.
JOURNAL OF VIROLOGY (2010)
Hepatitis C Virus Hypervariable Region 1 Modulates Receptor Interactions, Conceals the CD81 Binding Site, and Protects Conserved Neutralizing Epitopes
Dorothea Bankwitz et al.
JOURNAL OF VIROLOGY (2010)
A reporter cell line for rapid and sensitive evaluation of hepatitis C virus infectivity and replication
Michaela Iro et al.
ANTIVIRAL RESEARCH (2009)
Identification and Characterization of Broadly Neutralizing Human Monoclonal Antibodies Directed against the E2 Envelope Glycoprotein of Hepatitis C Virus
Teresa J. Broering et al.
JOURNAL OF VIROLOGY (2009)
Mutations in Hepatitis C Virus E2 Located outside the CD81 Binding Sites Lead to Escape from Broadly Neutralizing Antibodies but Compromise Virus Infectivity
Zhen-yong Keck et al.
JOURNAL OF VIROLOGY (2009)
Broadly neutralizing human monoclonal antibodies to the hepatitis C virus E2 glycoprotein
Ania M. Owsianka et al.
JOURNAL OF GENERAL VIROLOGY (2008)
Definition of a conserved immunodominant domain on hepatitis C virus E2 glycoprotein by neutralizing human monoclonal antibodies
Zhen-Yong Keck et al.
JOURNAL OF VIROLOGY (2008)
A point mutation leading to hepatitis C virus escape from neutralization by a monoclonal antibody to a conserved conformational epitope
Zhen-Yong Keck et al.
JOURNAL OF VIROLOGY (2008)
Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge
Mansun Law et al.
NATURE MEDICINE (2008)
Determination of the human antibody response to the epitope defined by the hepatitis C virusneutralizing monoclonal antibody AP33
Alexander W. Tarr et al.
JOURNAL OF GENERAL VIROLOGY (2007)
The neutralizing activity of anti-hepatitis C virus antibodies is modulated by specific glycans on the E2 envelope protein
Francois Helle et al.
JOURNAL OF VIROLOGY (2007)
Hepatitis C virus envelope glycoprotein E2 glycans modulate entry, CD81 binding, and neutralization
Emilia Falkowska et al.
JOURNAL OF VIROLOGY (2007)
Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C
Jan M. Pestka et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo
Thomas Von Hahn et al.
GASTROENTEROLOGY (2007)
N-linked glycosylation of folded proteins by the bacterial oligosaccharyltransferase
Michael Kowarik et al.
SCIENCE (2006)
Identification of conserved residues in the E2 envelope glycoprotein of the hepatitis C virus that are critical for CD81 binding
Ania M. Owsianka et al.
JOURNAL OF VIROLOGY (2006)
Definition of the bacterial N-glycosylation site consensus sequence
Michael Kowarik et al.
EMBO JOURNAL (2006)
Analysis of a highly flexible conformational immunogenic domain a in hepatitis C virus E2
ZY Keck et al.
JOURNAL OF VIROLOGY (2005)
Production of infectious hepatitis C virus in tissue culture from a cloned viral genome
T Wakita et al.
NATURE MEDICINE (2005)
Role of N-linked glycans in the functions of hepatitis C virus envelope glycoproteins
A Goffard et al.
JOURNAL OF VIROLOGY (2005)
Human serum facilitates hepatitis C virus infection, and neutralizing responses inversely correlate with viral replication kinetics at the acute phase of hepatitis C virus infection
D Lavillette et al.
JOURNAL OF VIROLOGY (2005)
The Los Alamos hepatitis C sequence database
C Kuiken et al.
BIOINFORMATICS (2005)
Monoclonal antibody AP33 defines a broadly neutralizing epitope on the hepatitis C virus E2 envelope glycoprotein
A Owsianka et al.
JOURNAL OF VIROLOGY (2005)
Hepatitis C virus E2 has three immunogenic domains containing conformational epitopes with distinct properties and biological functions
ZY Keck et al.
JOURNAL OF VIROLOGY (2004)
In vitro assay for neutralizing antibody to hepatitis C virus:: Evidence for broadly conserved neutralization epitopes
B Bartosch et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Cell surface expression of functional hepatitis C virus E1 and E2 glycoproteins
HE Drummer et al.
FEBS LETTERS (2003)
Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles
M Hsu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes
B Bartosch et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Human monoclonal antibodies that inhibit binding of hepatitis C virus E2 protein to CD81 and recognize conserved conformational epitopes
KG Hadlock et al.
JOURNAL OF VIROLOGY (2000)